510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K983147Substantially Equivalent

Accusign Doa 8, Accusign Doa 8 Panel, Accusign Thc/opi/coc/amp/bzo/bar/tca/pcp, Biosign Doa 8, Biosign Thc/opi/coc/amp/p

Princeton BioMeditech Corp., Princeton NJ / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)

K983147 is the FDA 510(k) clearance record for ACCUSIGN DOA 8, ACCUSIGN DOA 8 PANEL, ACCUSIGN THC/OPI/COC/AMP/BZO/BAR/TCA/PCP, BIOSIGN DOA 8, BIOSIGN THC/OPI/COC/AMP/P, a class II device, cleared for Princeton BioMeditech Corp. on under FDA product code DKE (Reagents, Test, Tetrahydrocannabinol). FDA records list 72 510(k) clearances for Princeton BioMeditech Corp., from to . As of , FDA records show no recalls naming K983147.

Clearance record

Decision date
Received
(20 days to decision)
Product code
DKE Reagents, Test, Tetrahydrocannabinol
Regulation
21 CFR 862.3870
Device class
Class II
Review panel
Clinical Toxicology
Applicant
Princeton BioMeditech Corp. P.O. Box 7139, Princeton NJ
510(k) summary
Statement
Third party review
No

Clearances, product code DKE

Trailing 12 months

FDA records hold no clearances under product code DKE in the trailing twelve months.

FDA records show no clearances under product code DKE in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code DKE, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260